The fusion gene BCR-ABL formed in CML decreases BCR transcription and BCR translation, and thus, there is no more BCR available to complex with β-catenin, leading to the translocation of β-catenin to the nucleus and Wnt/β-catenin pathway activation [48]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.